Rocket Lab (RKLB) has seen its stock surge nearly 250% over the past year, climbing from around $21 to over $73 per share. The company’s impressive growth is underscored by record revenue of $602 million in 2025, a 38% year-over-year increase, and a substantial backlog that has swelled to nearly $1.9 billion. With a 100% success rate across 21 missions, Rocket Lab is solidifying its position as a key player in the space industry, particularly with the upcoming launch of its Neutron rocket, which aims to compete directly with SpaceX’s Falcon 9.
However, investors should approach with caution. The stock currently trades at approximately 66 times sales, reflecting high expectations despite Rocket Lab’s ongoing losses, which totaled nearly $200 million last year. While the potential for growth exists, particularly if Neutron performs well, the risks associated with space flight and the stock’s valuation may deter more conservative investors.
In summary, Rocket Lab presents a compelling opportunity for risk-tolerant investors, but its high price tag and operational uncertainties make it a less attractive option for those seeking stability in their portfolios.
Source: fool.com